FB-102

N/A

Report date: 2025/05/23 20:00:56

Base Information

Drug NameFB-102
Drug Alias NameFB-102FB102
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionInterleukin-2 receptor beta chain antagonists
TargetsInterleukin-2 receptor beta chain
Therapy Area/IndicationsGraft vs Host DiseaseVitiligoAlopecia Areata +[5
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesNew ZealandAustralia
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesForte Biosciences Inc
China Registration ClassN/A

Develop Information

Active CompaniesForte Biosciences Inc
Inactive CompaniesN/A
Active IndicationsGraft vs Host DiseaseVitiligoAlopecia Areata +[4
Inactive IndicationsMalabsorption Syndromes

Other Information

ATC CodeN/A
Related LinksN/A